Amplia Therapeutics (Atx) Watclist 19 October 2023
Volume 0%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Enabled
Disabled
Play/Pause
SPACE
Increase Volume
↑
Decrease Volume
↓
Seek Forward
→
Seek Backward
←
Captions On/Off
c
Fullscreen/Exit Fullscreen
f
Mute/Unmute
m
Seek %
0-9
Next Up
Amplia Therapeutics (Atx) Watclist 19 October 2023 Sting
00:49
180p
270p
406p
720p
180p
1080p
Live
00:00
03:47
03:47
More Videos
00:49
Amplia Therapeutics (Atx) Watclist 19 October 2023 Sting
00:44
Amplia Therapeutics (ASX:ATX) set for AMP945 drug trials
00:53
Amplia Therapeutics (ASX:ATX) shows efficacy in model of lung fibrosis
00:43
Amplia Therapeutics (ASX:ATX) returns successful phase one trial results
00:40
Dr John Lambert resigns as CEO and MD from Amplia Therapeutics (ASX:ATX)
00:40
Amplia Therapeutics (ASX:ATX) receives final ethics clearance for Phase 2 trial
00:35
Amplia Therapeutics’ (ASX:ATX) pancreatic cancer study receives green light from US FDA
00:47
Data from Amplia Therapeutics (ASX:ATX) shows improved survival rates in pancreatic cancer model
Close
This video file cannot be played.
(Error Code: 224003)